| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |